Hong Kong · Delayed Price · Currency is HKD Duality Biotherapeutics Statistics
Total Valuation
HKG:9606 has a market cap or net worth of HKD 18.27 billion. The enterprise value is 15.20 billion.
| Market Cap | 18.27B |
| Enterprise Value | 15.20B |
Important Dates
The next estimated earnings date is Friday, November 27, 2026.
| Earnings Date | Nov 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:9606 has 90.54 million shares outstanding. The number of shares has increased by 259.84% in one year.
| Current Share Class | 90.54M |
| Shares Outstanding | 90.54M |
| Shares Change (YoY) | +259.84% |
| Shares Change (QoQ) | +1.85% |
| Owned by Insiders (%) | 12.79% |
| Owned by Institutions (%) | 54.66% |
| Float | 50.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 18.79 |
| PB Ratio | 10.91 |
| P/TBV Ratio | 10.93 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 15.63 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.99, with a Debt / Equity ratio of 0.26.
| Current Ratio | 1.99 |
| Quick Ratio | 1.85 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.46 |
| Interest Coverage | -469.72 |
Financial Efficiency
Return on equity (ROE) is -65.93% and return on invested capital (ROIC) is -38.81%.
| Return on Equity (ROE) | -65.93% |
| Return on Assets (ROA) | -24.30% |
| Return on Invested Capital (ROIC) | -38.81% |
| Return on Capital Employed (ROCE) | -84.65% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 3.65M |
| Profits Per Employee | -6.24M |
| Employee Count | 266 |
| Asset Turnover | 0.22 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.63% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -43.63% |
| 50-Day Moving Average | 193.61 |
| 200-Day Moving Average | 256.51 |
| Relative Strength Index (RSI) | 54.86 |
| Average Volume (20 Days) | 895,932 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:9606 had revenue of HKD 972.22 million and -1.66 billion in losses. Loss per share was -18.57.
| Revenue | 972.22M |
| Gross Profit | -269.76M |
| Operating Income | -1.72B |
| Pretax Income | -1.66B |
| Net Income | -1.66B |
| EBITDA | -1.71B |
| EBIT | -1.72B |
| Loss Per Share | -18.57 |
Balance Sheet
The company has 3.51 billion in cash and 438.08 million in debt, with a net cash position of 3.07 billion or 33.96 per share.
| Cash & Cash Equivalents | 3.51B |
| Total Debt | 438.08M |
| Net Cash | 3.07B |
| Net Cash Per Share | 33.96 |
| Equity (Book Value) | 1.67B |
| Book Value Per Share | 18.50 |
| Working Capital | 1.99B |
Cash Flow
In the last 12 months, operating cash flow was -945.38 million and capital expenditures -16.56 million, giving a free cash flow of -961.94 million.
| Operating Cash Flow | -945.38M |
| Capital Expenditures | -16.56M |
| Depreciation & Amortization | 10.69M |
| Net Borrowing | 356.37M |
| Free Cash Flow | -961.94M |
| FCF Per Share | -10.62 |
Margins
Gross margin is -27.75%, with operating and profit margins of -177.37% and -170.82%.
| Gross Margin | -27.75% |
| Operating Margin | -177.37% |
| Pretax Margin | -170.82% |
| Profit Margin | -170.82% |
| EBITDA Margin | -176.29% |
| EBIT Margin | -177.37% |
| FCF Margin | n/a |
Dividends & Yields
HKG:9606 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -259.84% |
| Shareholder Yield | -259.84% |
| Earnings Yield | -9.09% |
| FCF Yield | -5.26% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for HKG:9606 is 407.36, which is 101.86% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 407.36 |
| Price Target Difference | 101.86% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 7.08% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:9606 has an Altman Z-Score of 4.31 and a Piotroski F-Score of 1.
| Altman Z-Score | 4.31 |
| Piotroski F-Score | 1 |